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Ephrin kinases and their ephrin ligands transduce repulsion of
cells in axon guidance, migration, invasiveness, and tumor growth,
exerting a negative signaling on cell proliferation and adhesion. A
key role of their kinase activity has been confirmedbymutant kinase
inactive receptors that shift the cellular response from repulsion to
adhesion. Our present study aimed to investigate the role of low
molecular weight protein-tyrosine phosphatase (LMW-PTP) in
ephrinA1/EphA2 signaling. LMW-PTP, bymeans of dephosphoryl-
ation of EphA2 kinase, negatively regulates the ephrinA1-mediated
repulsive response, cell proliferation, cell adhesion and spreading,
and the formation of retraction fibers, thereby confirming the rele-
vance of the net level of tyrosine phosphorylation of Eph receptors.
LMW-PTP interferes with ephrin-mediated mitogen-activated
protein kinase signaling likely through inhibition of p120RasGAP
binding to the activated EphA2 kinase, thereby confirming the key
role of mitogen-activated protein kinase inhibition by ephrinA1
repulsive signaling.We conclude that LMW-PTP acts as a termina-
tor of EphA2 signaling causing an efficient negative feedback loop
on the biological response mediated by ephrinA1 and pointing on
tyrosine phosphorylation as themain event orchestrating the repul-
sive response.
TheEph family of receptor tyrosine kinases and their ligands, ephrins,
constitute the largest receptor tyrosine kinase subfamily, with at least 16
receptors and 9 ligands (1, 2) (cbweb.med.harvard.edu/eph-nomencla-
ture). So far, several biological functions have been attributed to Eph
receptors including cell positioning, vascular development, tissue bor-
der formation, branching morphogenesis, cell migration, and axon
guidance (2). In any case, the influence on cell behavior of ligand-in-
duced Eph receptor activation can generally be related to repulsion of
neighboring cells or of cellular processes, such as neuronal growth cone
(3) or vasculogenesis (4).
Engagement with an ephrin induces a conformational change in the
cytoplasmic portion of the Eph receptor triggered by phosphorylation of
two juxtamembrane tyrosines (5), which relieves kinase domain inhibi-
tion (6). Occupancy of the juxtamembrane binding sites and additional
phosphorylation may further stabilize the active conformation of the
Eph receptor, thereby stimulating the activity of the kinase domain.
Furthermore, receptor tyrosine phosphorylation creates docking sites
for proteins with SH2 3 or phosphotyrosine binding domains, leading
to the recruitment of cytoplasmic targets that regulate downstream
signaling (7).
Both Eph kinases and ephrins have been implicated in tumor growth
and angiogenesis. They have been found to be overexpressed in many
human tumors (8–11), and the higher expression levels correlated with
the more aggressive and metastatic tumors (10, 12). Elevated EphA2
levels are observed inmany dissimilar types of cancers, including breast,
prostate, and colon carcinomas, as well as in aggressive melanomas
(13–15). In addition, ectopic overexpression of EphA2 is sufficient to
grant tumorigenic and metastatic potential upon nontransformed epi-
thelial cells (14).
Notably, the presence within the same cell of kinase-inactive in con-
cert with wild-type Eph receptors transforms its outcome to ephrins
from repulsion to adhesion (16), suggesting that net levels of Eph kinase
tyrosine phosphorylation determine the response to ephrin contact.
Although phosphorylation is thought to be an important event in the
Eph receptor signaling process, the specific role of Eph kinase activity
and of associated phosphatases remains to be elucidated. Emerging evi-
dence suggests that protein-tyrosine phosphatases (PTPs) are involved
in regulating Eph-mediated responses (17–20). Recruitment of low
molecular weight (LMW)-PTP to ephrinB1-activated EphB2 is impor-
tant for endothelial capillary-like assembly and adhesion (21). In addi-
tion, LMW-PTP is frequently overexpressed in transformed cells, and
its ectopic overexpression is sufficient to confer transformation in epi-
thelial cells (22), thus suggesting a role for LMW-PTP in transformation
progression. Although recent data suggest that LMW-PTP in vivo is a
positive regulator of both tumor onset and development and that the
oncogenic potential of the phosphatase is linked to EphA2 (17), the
specific role of this phosphatase in the modulation of the ephrin-medi-
ated cellular response is still unknown.
Herein we demonstrate that LMW-PTP negatively regulates the
repulsive response elicited by ephrinA1 through dephosphorylation of
EphA2 kinase, thereby confirming the relevance of the net level of tyro-
sine phosphorylation of Eph receptors. Our results identify LMW-PTP
as a negative regulator of the activated EphA2 kinase, ultimately inter-
fering with ephrin-mediated mitogen-activated protein kinase (MAPK)
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EXPERIMENTAL PROCEDURES
Materials—Unless otherwise specified all reagents were obtained
from Sigma. PC3 and HEK-293T cells were purchased from ATCC.
Recombinantmouse Fc and ephrinA1-Fc chimera fromwere fromR&D
Systems. Anti-MAPK, antiphosphotyrosine (clone 4G10), and anti-
EphA2 antibodies were from Upstate Biotechnology Inc. Anti-phos-
pho-MAPK antibodies were from Cell Signaling Technology, and anti-
p120RasGAP was from Santa Cruz Biotechnology. Mouse embryonic
fibroblasts (MEFs) that are wild type or null for p120RasGAP were
kindly supplied by Tony Pawson (Toronto, Canada).
Cell Culture and Stimulation—PC3 cells were cultured inHam’s F-12
medium; MEFs and HEK-293T cells were cultured in Dulbecco’s mod-
ified Eagle’smedium. 10% fetal calf serumwas added to allmedia, and all
cells were maintained in 5% CO2 humidified atmosphere. For studies
using soluble ephrinA1, cells in logarithmic growth phase were always
stimulated with 1 g ml1 Fc or ephrinA1-Fc for the indicated times.
Cloning of Human Eph Receptor—On the basis of the human EphA2
BLAST sequence (M59371) we synthesized the primers for reverse
transcription-PCR: upstream primer, 5-ATGGAGCTCCAGGCAGC-
CCG-3; and downstream primer, 5-TCAGATGGGGATCCCCA-
CAGT-3. Total RNA was isolated from PC3 cells with TRIzol reagent
(Invitrogen), and the amplification was performed using SuperScript
One-step reverse transcription-PCR for long templates (Invitrogen)
according to the manufacturer’s instructions. The amplified sequence
was subcloned into pLargeT vector (Promega). The double mutant
EphA2 receptor was obtained using a QuikChange XL Site-directed
Mutagenesis kit (Stratagene). The original tyrosines in positions 588
and 594 have been replaced with phenylalanine.
DNA Transfection—8 g of pRcCMV-wtLMW-PTP or pEGFP-
wtLMW-PTP, in which wild-type LMW-PTP has been cloned
upstream of the ATG-deleted EGFP gene of the pEGFP-N1 vector (23),
or the wild-type and mutant EphA2 kinase in pLargeT vector, were
transiently transfected in PC3 or in HEK-293T cells using Lipo-
fectamine 2000 (Invitrogen). 48 h after transfection cells were recovered
for analyses.
Short Interfering RNA (siRNA) Transfections—LMW-PTP siRNA
(5-AAGTCCGTGCTGTTTGTGTGT-3), p120RasGAP siRNA (5-
AAACTGCCCACTTCGTTGCTT-3), and a negative control siRNA
sequence corresponding to nucleotides 695–715 of the firefly luciferase
(U31240) were obtained from Qiagen. PC3 cells plated at 3 105/dish
were transfectedwith siRNAs using Lipofectamine 2000 as described by
the manufacturer. Cells were transfected with 4 g of siRNA/60-mm
dish. siRNA efficiency was tested by anti-LMW-PTP immunoblot;
although at 48 h we detected an appreciable inhibition of LMW-PTP
expression, the best efficiency was observed 72 h after transfection.
Cell Adhesion onto EphrinA1-Fc-coated Slides—Coverslips were
treated with 2% collagen in PBS for 15min and then washed extensively
with PBS and air dried. After that, the slides were coated with 1 g/ml
ephrinA1-Fc for 1 h at room temperature and then washed twice with
2% bovine serum albumin in Dulbecco’s modified Eagle’s medium.
1.2 105 cells were seeded in each coverslip, and adhesion was permit-
ted for 15 min, 30 min, and 1 h. Negative controls were performed by
seeding cells onto collagen-coated and ephrinA1 noncoated coverslips.
Afterward an immunohistochemistry assay was performed using
phalloidin-TRITC.
Clonal Cell Growth Assay—200 cells were plated in triplicate directly
onto 6- or 12-well cell culture dishes in the presence of Fc or ephrinA1-
Fc; media were changed every 3 days. Cellular growth was stopped after
7–10 days in culture by removing the medium and by the addition of a
0.5% crystal violet solution in 20%methanol. After staining for 5min the
fixed cells were washed with PBS and solubilized with 200 l/well 0.1 M
sodium citrate, pH 4.2. The absorbance at 595 nmwas evaluated using a
microplate reader.
In Vitro Three-dimensional Migration Assay—The in vitro motility
assays were carried out with the Costar Transwell system, equipped
with 8-m pore polyvinylpyrrolidone-free polycarbonate filters (diam-
eter, 13 mm). The Matrigel (BD Biosciences) was diluted (30 g in 100
l of H2O), added to the top chamber, allowed to gel for 1 h at 37 °C, air
dried for 16 h, and theMatrigel barrier was reconstituted with 100l of
medium for 2 h at 37 °C before use. Cells were loaded to the upper
compartment (5  104 cells in 300 l) in serum-deprived growth
medium with or without 1 g ml1 ephrinA1. The Matrigel invasion
chambers were placed into 6-well culture dishes containing 1 ml of
mediumwith 20% serumas chemoattractant. After 24 h of incubation at
37 °C, noninvading cells and the Matrigel layer were removed mechan-
ically using cotton swabs, and the microporous membrane containing
the invaded cells was fixed in 96% methanol and stained with a crystal
violet. Chemotaxis was evaluated by counting the cells migrated to the
lower surface of the polycarbonate filters. For each filter the number of
cells in six randomly chosen fields was determined, and the counts were
averaged (mean S.D.).
Wound Healing Migration Assay—Confluent PC3 cells were serum
starved for 24 h, and the dishes were scored with a sterile 200-l
micropipette tip and photographed. Thereafter cells were treated with
50 ng/ml epidermal growth factor (EGF) and 1 g/ml of either Fc or
ephrin-Fc After 24 h the wounds were photographed again to visualize
incoming cells.
Immunocytochemistry—After washing with PBS, cells were fixed
with 3.7% formaldehyde solution in PBS for 20 min at 4 °C. Then, after
extensive washes in PBS, cells were permeabilized with 0.1% Triton
X-100 in PBS and then stained with a 50 g/ml fluorescent phalloidin
conjugate solution in PBS, phalloidin-TRITC, for 1 h at room temper-
ature. After several washes with PBS to remove unbound phalloidin
conjugate, the coverslides were mounted with glycerol plasticine and
then observed under a confocal fluorescence microscope.
Immunoprecipitation andWestern Blot Analysis—1 106 cells were
lysed for 20 min. on ice in 500 l of complete RIPA lysis buffer (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 2 mM EGTA, 1 mM
sodium orthovanadate, 1 mM phenylmethanesulfonyl fluoride, 10
g/ml aprotinin, 10 g/ml leupeptin). Lysates were clarified by centrif-
ugation and immunoprecipitated for 4 h at 4 °C with 1–2 g of the
specific antibodies. For anti-EphA2 immunoprecipitation we used
either anti-EphA2 antibodies (Upstate Biotechnologies) or 1 g ml1
ephrinA1-Fc fusion protein, which precipitates all EphA kinases with
similar results. Immune complexes were collected on protein A-Sepha-
rose, separated by SDS-PAGE, and transferred onto nitrocellulose.
Immunoblots were incubated in 3% bovine serum albumin, 10mMTris-
HCl, pH 7.5, 1 mM EDTA, and 0.1% Tween 20 for 1 h at room temper-
ature, probed first with specific antibodies and then with secondary
antibodies. Quantity-One software (Bio-Rad) was used to perform
quantitative analyses.
RESULTS
EphA2 Inhibits Cell Proliferation andCellMigration and Induces Cell
Rounding and Retraction Fiber Formation—To study the role and reg-
ulation of tyrosine phosphorylation of EphA2 receptor we chose PC3
carcinoma cells, which have been reported to express mainly EphA2
kinase (24). Herein we report that the stimulation of this receptor by its
cognate ligand ephrinA1 elicits a growth arrest response together with
inhibition of cell migration. PC3 cells were seeded onto collagen-coated
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dishes, and a clonal growth assay was carried out (Fig. 1A). Moreover,
ephrinA1 treatment of PC3 cells inhibits their EGF-induced migration
in a three-dimensional motility assay (Fig. 1B). The inhibition of eph-
rinA1 on cell motility was assessed further by a wound healing migra-
tion assay. Confluent PC3 cells were wounded, and their EGF-induced
motility was measured in the presence of ephrinA1 (Fig. 1C). Again,
ephrinA1 is able to inhibit the cell motility strongly in response to EGF
as a chemoattractant.
FIGURE 1. EphA2 inhibits cell proliferation and cellmigration and induces cell rounding and retraction fiber formation.A, cell growth assay. PC3 cells were plated in complete
medium in the presence of Fc or ephrinA1-Fc. Cellular growthwas stopped after 7–10 days, and crystal violet (CV)-stained cells were evaluated and reported in the plot. Themean
S.D. are indicated.B, three-dimensional cellmigration assay. PC3 cells, after 24hof serumstarvation,were seeded into theupper chamberof Transwell precoatedwith amatrigel layer
and treated with Fc or ephrinA1-Fc. Cell were allowed to migrate for 24 h toward the lower chamber filled with growth medium supplemented with 20% fetal calf serum. Cell
migration was evaluated after crystal violet staining by counting cells in six randomly chosen fields. The average cell number is reported in the histogram, and the mean S.D. are
indicated. C, wound healing migration assay. Confluent PC3 were serum starved for 24 h, scratched with a tip, and a photograph was taken. 50 ng/ml EGF was added to induce
migration together with 1g/ml Fc or ephrinA1-Fc, and after 24 h another photographwas taken. The experimentwas repeated four timeswith similar results.D, cell adhesion onto
ephrinA1-Fc-coated slides. Cells were seeded onto Fc- or ephrinA1-Fc-coated coverslips, and adhesion was permitted for 1 h. Confocal microscope analysis after phalloidin-TRITC
immunostaining is shown. E, formation of ephrinA1-induced retraction fibers. Cells were seeded onto collagen-coated coverslips, and adhesion was permitted for 24 h. Thereafter
ephrinA1-Fc or Fc stimulation was carried out for 15 min. Confocal microscope analysis after phalloidin-TRITC immunostaining is shown.
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Many findings have reported that EphA2 activation leads to dramatic
changes in cell morphology (3, 19, 25, 26).We observed that in PC3 cells
EphA2 activation inhibits the spreading and adhesion of cells onto col-
lagen-treated dishes (Fig. 1D), suggesting a dramatic delay, after contact
with the extracellular matrix, in the construction of cytoskeleton archi-
tecture, because of ephrinA1 stimulation. In addition, ephrinA1 stimu-
lation, while inducing cell retraction from the original spread morphol-
ogy, provokes the formation of actin retraction fibers (Fig. 1E), resulting
from retraction of extending membranes of rounding cells. Retraction
fibers have been reported to form in several circumstances in which
cells need to round up, as in preparation for cell division (27) and during
neurite retraction (28). These fibers are not microspikes/filopodial-like
projections but simple residual contact sites that have not yet been
released from the substrate. As far as we know this is the first evidence
that during the retraction of the cell body, EphA2 receptor activation
elicits the formation of branching actin structures, similar to retraction
fibers.
EphA2 Receptor Is Regulated by LMW-PTP—A role of LMW-PTP in
the dephosphorylation of EphA2 has already been postulated, first in
vitro (22) and in vivo (17). Our current interest was in investigating the
role of LMW-PTP in ephrinA1 signaling. Immunoprecipitation analysis
in PC3 cells reveals that EphA2 receptor associates with LMW-PTP and
FIGURE 2.EphA2 receptor is regulatedby LMW-PTP.A, association of LMW-PTPwith activated EphA2 receptor. PC3 cellswere serum starved for 24 hbefore stimulatingwith either
Fc or ephrinA1-Fc for the indicated times. LMW-PTPwas immunoprecipitated (Ip), and ananti-EphA2 immunoblot (Wb)wasperformed. Theblotwas then strippedand reprobedwith
anti-LMW-PTP antibodies for normalization.B, LMW-PTP silencingusing siRNA. PC3 cellswere treated as inA and then lysed in RIPA lysis buffer. 25gof total proteins for each sample
was analyzed by anti-LMW-PTP immunoblot. C andD, LMW-PTP controls the EphA2 tyrosine phosphorylation. PC3 cells, in which LMW-PTP was either silenced (C) or overexpressed
(D) for 72 h, were treated as in A. LMW-PTP silencing and overexpression were checked by anti-LMW-PTP immunoblot. EphA2 receptor was immunoprecipitated, and its tyrosine
phosphorylation level was evaluated by antiphosphotyrosine (4G10 clone) immunoblot. The blotwas then stripped and reprobedwith anti-EphA2 antibodies for normalization. The
graph obtained with data from densitometry analysis of replicate experiments plotted relative to loading controls is shown below.
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FIGURE 3. EphrinA1 repulsive outcome is regulated by LMW-PTP. A, three-dimensional cell migration assay. PC3 cells, in which LMW-PTP was silenced for 72 h, after 24 of serum
starvation, were seeded with Fc or ephrinA1-Fc, into the upper chamber of a Transwell precoated with a matrigel layer. Cell were allowed to migrate for 24 h toward the lower
chamber filledwith growthmediumsupplementedwith 20% fetal calf serum. Cellmigrationwas evaluated after crystal violet stainingby counting cells in six randomly chosen fields.
The average cell number S.D. is reported in the bar graph. LMW-PTP silencing was checked by anti-LMW-PTP immunoblot. B, LMW-PTP is involved in cell rounding and retraction
fiber formation. Cells were seeded onto collagen-coated coverslips andwere treated as in B except that F-actinwas stained by anti-phalloidin-TRITC treatment. Confocalmicroscope
analysis is shown. C, as a quantification of the phenomenon, cells with actin retraction fibers longer than half the diameter of the cell body were counted. Values represent the
LMW-PTP Regulates EphA2 Repulsive Response
34012 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 280•NUMBER 40•OCTOBER 7, 2005
that this association is strictly ligand-dependent (Fig. 2A). To verify that
LMW-PTP is able to dephosphorylate EphA2 in PC3 cells, we first used
the siRNA-based silencing approach. We initially verified that 48 and
72 h after siRNA transfection the expression of LMW-PTP was almost
undetectable and that the effect of siRNA-mediated LMW-PTP silenc-
ing was not affected by ephrinA1 stimulation (Fig. 2B). LMW-PTP
silencing did not affect either the EphA2 expression or the overall cell
morphology (data not shown). Further analysis with LMW-PTP-si-
lenced PC3 cells revealed that the tyrosine phosphorylation level of
EphA2 kinase upon ligand binding was greatly affected by LMW-PTP
silencing (Fig. 2C). These data suggest that LMW-PTP retains a key role
in the dephosphorylation of the receptor kinase, although other phos-
phatases may be involved in EphA2 signaling termination. Overexpres-
sion of wtLMW-PTP in PC3 cells confirms that LMW-PTP is able to
dephosphorylate the EphA2 kinase, leading to a significant decrease in
EphA2 kinase phosphorylation level (Fig. 2D).
EphA2 Function Is Regulated by LMW-PTP—Recent data indicate
that the presence of kinase-inactive, together with active Eph receptors
within the same cell, changes its response to ligands from repulsion to
adhesion (16, 29), indicating a key role for Eph kinase phosphorylation
levels. Consequently, we hypothesize that ephrinA1 cellular responses
are controlled by the activity of the associated LMW-PTP. To verify that
LMW-PTP is able to contrast ephrinA1 effects in PC3 cells, we first
analyzed the effect of modulation of LMW-PTP expression on ephrin-
mediated migration responses. Our results showed that LMW-PTP
silencing causes a dramatic increase in the effect elicited by ephrinA1 in
the three-dimensional motility assay, leading to a greater inhibition of
serum-induced cell migration (Fig. 3A).
Furthermore, we analyzed the effect of LMW-PTP silencing on
the ephrin-mediated formation of retraction fibers, observed during
cell repulsion. Remarkably, both the repulsion between ephrinA1
cells and the formation of retraction fibers appear to be enhanced (at
least 65%) in LMW-PTP-silenced cells (Fig. 3, B and C). In addition,
to confirm the causal role of LMW-PTP in cell rounding and retrac-
tion fiber formation, we overexpressed the EGFP-fused wtLMW-
PTP in PC3 cells during ephrinA1 stimulation. We checked that the
overexpression of LMW-PTP had not influenced the overall cell
rounding and retraction fiber formation in PC3 cells and that the
fusion of LMW-PTP with EGFP had not interfered with its enzy-
matic activity (data not shown). Fig. 3D shows the superimposing of
green fluorescence of EGFP (cells that express EGFP-wtLMW-PTP)
and of red fluorescence from actin labeling. Upon stimulation with
EphA1 all of the cells started to retract the cell body at 5 min. By 15
min, nearly all of the cells retracted the membrane protrusions, and
the actin retraction fibers were evident. In EGFP-wtLMW-PTP-ex-
pressing cells the formation of retraction fibers was strongly inhib-
ited, whereas in adjacent nonexpressing cells the formation of
retraction filaments was normal (Fig. 3D). Fig. 3E shows a quantita-
tive analysis of the morphological changes, namely, loss of mem-
brane extensions and formation of retraction fibers in both wtLMW-
PTP and control cells. Finally, the effect of LMW-PTP silencing was
assessed in a wound-healing EGF-induced motility assay (Fig. 3F),
confirming again that the inhibition of expression of LMW-PTP
considerably increases the decline in cell motility induced by
ephrinA1.
Thus, taken together our data indicate that LMW-PTPhas a dramatic
effect on the overall repulsive outcome induced by ephrinA1 ligation.
LMW-PTP Interferes with Ephrin-mediated MAPK Regulation—MAPKs
play an essential role in a variety of cellular processes such as proliferation,
migration, and development and were recently found to be linked to ephrin
signaling (24, 26, 30–32). Although the effect of ephrins on MAPKs is still
debated, in ephrinA1-stimulatedPC3cellswedetecteda strongandclear inhi-
bition of this signaling pathway. The effect of ephrinA1 on the basal MAPK
activation level was first analyzed and found to be mainly integrin- and cell
adhesion-dependent. The results are consistent with previously reported data
(24) and show that ephrinA1 strongly inhibits basal MAPK activity (Fig. 4A).
Next, to elicit a strong MAPK activation, we stimulated PC3 cells with EGF.
Again, ephrinA1was able to inhibit strongly the EGF-inducedMAPK activa-
tion (Fig. 4B), confirming that cell repulsion is associatedwith the repressionof
MAPKs elicited by both adhesivemolecules and by solublemitogens.
To investigate the role of LMW-PTP in EphA2-mediated inhibition
of MAPK signaling, we either silenced LMW-PTP expression or over-
expressed wtLMW-PTP, before MAPK assaying. We show that the
inhibition of LMW-PTP expression induces a stronger inhibition of
MAPK after ephrinA1 stimulation, likely because of EphA2 receptor
hyperphosphorylation (Fig. 4C). Likewise, the overexpression of active
LMW-PTP leads to the abolishment of the inhibitory effect of ephrinA1
onMAPK activation, likely because of receptor dephosphorylation (Fig.
2D). Taken together, our results validate that LMW-PTP greatly affects
EphA2-dependent signaling, contrasting ephrin-dependent MAPK
inhibition.
LMW-PTP Inhibits p120RasGAP Binding to EphA2 Kinase—p120Ras-
GAP has been indicated among SH2 domain-containing proteins that, upon
ligandbinding, bind toEphkinases (33). The recruitment to cellmembrane of
the Ras small GTPase GAP leads to activation of its GTPase activity and to a
final down-regulation of MAPK signaling (34). We hypothesized that the
LMW-PTP effect on ephrinA1-mediatedMAPK signaling may be caused by
the eliminationof a docking site (either single ormultiple) for aMAPKregula-
tor containing an SH2 domain as p120RasGAP. To verify our hypothesis we
analyzed the binding of p120RasGAP toEphA2kinase in LMW-PTP silenced
cells. Our results indicate that killing of LMW-PTP enhances p120RasGAP
binding to EphA2 receptor (Fig. 5A), suggesting a role for this phosphatase in
the dephosphorylation of p120 binding site(s) on the activated receptor.
Accordingly, inPC3cellsoverexpressingwtLMW-PTPwereportedadecrease
intheamountofp120RasGAPboundtoEphA2kinaseuponligandstimulation
(Fig. 5B).
The involvement of p120RasGAP in the down-regulation of MAPK
in response to Eph receptors has already been proposed (32). To con-
firm the key role of p120RasGAP in ephrinA1 signaling, we investigated
the activation level of MAPK in wild-type cells and in cells in which
p120RasGAP has been silenced by RNA interfering. Stimulation of cells
with ephrinA1 leads to a dramatic down-regulation of EGF-activated
MAPK, whereas no change in MAPK activation was detected in
p120RasGAP-silenced cells (Fig. 6A). In addition we analyzed the inhi-
bition ofMAPKby ephrinA1 in p120RasGAP-nullMEFs (Fig. 6B), again
demonstrating that the absence of this GAP completely abolishes the
meanS.D. from six randomly selected fields. D, cells were coated onto collagen-coated coverslips and were treated as in B and C except that EGFP-LMW-PTP was overexpressed
72 h before ephrinA1-Fc and Fc alone treatment for 15 min. Confocal microscope analysis is shown: top panel, red fluorescence of F-actin stained with anti-phalloidin-TRITC;middle
panel, green fluorescence of EGFP; and bottom panel, superimposition of both fluorescences. E, the number of cells that retractmembrane extensions inwhich actin retraction fibers
are evident, together with total number of cells per field, were counted in six randomly chosen fields. Values represent the mean percentageS.D. from six different positions. F,
woundhealingmigration assay. Confluent PC3 cells, inwhich LMW-PTPwas silenced for 72h,were serumstarved for 24h, scratchedwith a tip, and aphotographwas taken. 50 ng/ml
EGF was added to induce migration together with 1 g/ml Fc or ephrinA1-Fc, and after 24 h another photograph was taken. LMW-PTP silencing was checked by anti-LMW-PTP
immunoblot. The experiment was repeated four times with similar results.
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FIGURE 4. LMW-PTP interferes with ephrin-mediated MAPK regulation. A, ephrinA1 inhibits basal MAPK activity. PC3 cells were serum starved for 24 h before stimulating with either Fc or
ephrinA1-Fc for the indicated times. Cellswere then lysed inRIPA lysis buffer, and25gof total proteins for each samplewasanalyzedbyanti-phospho-MAPK immunoblot (Wb). Theblotwas then
strippedandreprobedwithanti-MAPKantibodiesfornormalization.B,ephrinA1inhibitsEGF-inducedMAPKactivity.CellsweretreatedasinAexceptthattheywerestimulatedwith50ng lEGFwith
orwithoutephrinA1-Fc.MAPKactivationwasevaluatedas inA.CandD, LMW-PTPinvolvement inMAPKregulationbyephrinA1.Cellsweretreatedas inAexceptthatLMW-PTPwaseithersilenced(C)
or overexpressed (D) for 72 h. LMW-PTP silencing and overexpression were checked by anti-LMW-PTP immunoblot. MAPK activation was evaluated as in A. The graph obtained with data from
densitometryanalysisof replicateexperimentsplotted relative to loadingcontrols is shownbelow.
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ephrin-mediatedMAPK inhibition. Furthermore, the overexpression of
wtLMW-PTP in wild-type MEFs powerfully impedes the inhibition of
MAPK, strongly resembling the p120RasGAP-null phenotype (Fig. 6B).
Taken together, these data suggest that the ability of ephrinA1 to down-
regulate the MAPK pathway mainly depends on the expression of its
negative regulator, namely p120RasGAP and that LMW-PTP is
involved in this signaling pathway.
The binding of p120RasGAP to two juxtamembrane sites in EphB2
receptors has already been reported (33). To confirm the role of
p120RasGAP and LMW-PTP in EphA2 signaling we analyzed the bind-
ing sites of both of these molecules to EphA2 kinase. Sequence compar-
ison between EphA2 and EphB2 indicates Tyr-588 and Tyr-594 in
EphA2 kinase as possible p120RasGAP binding sites. We mutated both
of these sites and transiently overexpressed wild-type and double
mutant EphA2 kinase in HEK-293T cells, which show very low endog-
enous EphA2 level. Our results show that the binding of both
p120RasGAP and LMW-PTP is greatly impaired by Tyr-588 and Tyr-
594 mutations, suggesting that these two tyrosines behave as ligand-
induced binding sites for both p120RasGAP and LMW-PTP (Fig. 6, C
and D).
Taken together these data suggest that LMW-PTP may inhibit the
binding of p120RasGAP to activated EphA2 receptor, likely because of
dephosphorylation of the docking site(s) on the stimulated receptor.
The competition for the same site between LMW-PTP and
p120RasGAP likely leads to the abolishment of the inhibitory effect on
MAPK elicited by ephrinA1.
DISCUSSION
Data presented herein indicate that LMW-PTP negatively regulates
the repulsive response elicited by ephrinA1 and interferes with the
ephrin-mediated regulation of proliferation, motility outcome, cell
adhesion, and spreading, as well as the formation of retraction fibers.
LMW-PTP acts as a terminator of ephrinA1 signaling through
dephosphorylation of the EphA2 kinase, particularly interfering with
ephrin-mediated MAPK signaling through p120RasGAP binding.
These data confirm the relevance of the net level of tyrosine phospho-
rylation of Eph receptors and their key role in the inhibition of MAPK
signaling through p120RasGAP recruitment, in the regulation of the
motility outcome elicited by the ephrin ligand during epithelial cell
communications.
Our data point to the tyrosine phosphorylation level of EphA2 as the
molecular motor of the repulsive response elicited by the ligand. Previ-
ous data indicated the ability of LMW-PTP to dephosphorylate the
EphA2 kinase (17, 22). The dephosphorylation of EphA2 kinase by
LMW-PTP was found to be linked to the phosphatase tumorigenic
potential because LMW-PTP overexpression is sufficient to induce
FIGURE 5. LMW-PTP inhibits p120RasGAPbinding to EphA2kinase. PC3 cells were serum starved for 24 h before stimulatingwith either Fc or ephrinA1-Fc for the indicated times.
LMW-PTPwas either silenced (A) or overexpressed (B) for 72h. EphA2was immunoprecipitated, andananti-p120RasGAP immunoblotwasperformed. Theblotwas then strippedand
reprobed with anti-EphA2 antibodies for normalization. LMW-PTP silencing and overexpression were checked by anti-LMW-PTP immunoblot. The graph obtained with data from
densitometry analysis of replicate experiments plotted relative to loading controls is shown below.
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FIGURE 6. Role of p120RasGAP and LMW-PTP in ephrinA1-mediated MAPK down-regulation. A, PC3 cells, in which p120RasGAP was silenced for 72 h or not, were serum
starved for 24 h before stimulating with 50 ng/ml EGF with or without ephrinA1-Fc for 15 min. Cells were then lysed in RIPA lysis buffer, and 25 g of total proteins for each
sample was analyzed by anti-phospho-MAPK immunoblot (Wb). The blot was then stripped and reprobed with anti-MAPK antibodies for normalization. B, MEFs that are wild
type or null for p120RasGAP were serum starved for 24 h before stimulating with ephrinA1-Fc for 15 min. Cells were then lysed and samples treated as in A. Where indicated,
wtLMW-PTP was transiently overexpressed for 72 h. C and D, HEK-293T cells were transiently transfected with wild type (wt) and double mutant (dm) EphA2 kinase for 72 h,
serum starved for 24 h, and then stimulated either with ephrinA1-Fc or Fc alone for 15min. EphA2was immunoprecipitated (Ip), the samples were blotted onto nitrocellulose,
and the filter was cut. The upper part was used for an anti-p120RasGAP immunoblot (C) and the lower part was used for an anti-LMW-PTP immunoblot (D). The upper part of
the blot was then stripped and reprobed with anti-EphA2 antibodies for normalization. The graph obtained with data from densitometry analysis of replicate experiments
plotted relative to loading controls is shown below.
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transformation upon nontransformed epithelial cells and greatly
enhances the onset and the proliferation rate of solid tumors in nude
mice (17, 22). In keeping with these findings we report herein that both
overexpression and silencing of LMW-PTP affect the tyrosine phospho-
rylation level of EphA2 kinase. Hence, in addition to platelet-derived
growth factor, EGF, fibroblast growth factor, and insulin receptors,
EphA2 kinase has to be included among LMW-PTP-regulated receptor
tyrosine kinases. Therefore, for both proliferative and repulsive signals
elicited by receptor tyrosine kinase ligands PTP-mediated termination
of the signal represents a conserved component of the biochemical
machinery triggered by ligands.
LMW-PTP silencing leads to a strong decrease of dephosphorylation
although not to a constitutive activation of EphA2 kinase. Because the
activation level of a kinase is a balance between the autophosphorylation
activity and the counteracting activity of associated PTPs, this effect
may be the result of both internalization/degradation of activated
EphA2 receptors upon ligand binding or other PTPs next to LMW-PTP.
Other PTPs implicated in Eph/ephrin signaling include Src homology
phosphatase-2, PTP-basophil-like and PTP-3 (19, 20, 35). Src homology
phosphatase-2 is rapidly and transiently recruited to ephrinA1-acti-
vated EphA2 and is implicated in the loss of integrin-mediated cell-
adhesion (19). Interestingly, also EphB receptor signaling may be nega-
tively regulated by PTP activity as indicated by the ability of PTP-
basophil-like, recruited to the ephrinB PDZ targeting site, to
dephosphorylate ephrinB1.
Literature on tyrosine phosphorylation of Eph receptors is largely
unclear. Tyrosine phosphorylation of EphA2 has been reported to reg-
ulate receptor protein stability and is responsible for the recruitment of
c-Cbl adapter protein associated with receptor internalization (37). In
addition, Holmberg et al. (16) reported that the expression of kinase-
defective Eph receptor dominates the repulsive response of the full-
length receptor, thus abolishing the response to ephrins and suggesting
that the level of tyrosine phosphorylation can determine whether a cell
responds to its ligand with repulsion or not. On the other hand, recent
data revealed that Ephs and/or ephrins retain some tyrosine phospho-
rylation-independent functions, keeping the debate alive about the role
of tyrosine phosphorylation in ephrin signaling (38–40). In the present
study we report that the down-regulation of the tyrosine phosphoryla-
tion level of EphA2 by LMW-PTP is followed by the inhibition of the
cellular outcomes induced by ephrinA1. In particular we report that
LMW-PTP interferes with all of the main phenotypic effects elicited by
ephrinA1, namely with the formation of retraction fibers, with the inhi-
bition of the cytoskeleton organization during cell adhesion and spread-
ing, and with the inhibition of cell proliferation. Our findings strongly
suggest that all of these outcomes elicited by ephrinA1 are guarded by
the phosphorylation of EphA2 kinase.
Herein we reported that LMW-PTP dephosphorylation of EphA2
kinase leads to the abolishment of MAPK inhibition exerted by eph-
rinA1, and we suggest that this effect is likely achieved through the
elimination of a binding site for p120RasGAP on the activated EphA2
kinase. The effect of Eph onMAPKs is debated. Although there are few
manuscripts showing an increase inMAPK activity following ephrinA1
stimulation (31, 41), there is accumulating evidence that ephrinA1
causes the inhibition ofMAPK activity in epithelial cells during branch-
ing morphogenesis (26) and neurite collapse (30). Our present data,
showing that in PC3 cells ephrinA1 causes the inhibition of both basal
and EGF-induced MAPK activity, are in agreement with the last evi-
dence, thus contributing to the depiction of ephrins as negative modu-
lators of MAPK-dependent outcomes. Notably, the data on ephrin-me-
diated inhibition of EGF-induced MAPKs suggest that the power of
repulsive factors exceeds the proliferative stimulus induced by a growth
factor. Thus, when cells respond to multiple signals, which is the most
frequent situation, the repulsive/antiproliferative signal is dominant
upon the mitotic/motile signal and the site of the conflict is MAPK
activity.
The opposite effects of Eph activation onMAPK activity described in
literature may be partially explained by the specificity of binding to
inhibitors and activators of theMAPK pathway. In most cases, the acti-
vating effect of Eph receptors is mediated by direct or indirect employ-
ment of the Grb2Sos1 complex, which acts as a Ras-specific GTP
exchange factor (31, 41). Activated EphA2 and B2 receptors down-reg-
ulate the Ras/MAPKpathway in neuronal and endothelial cells by direct
recruitment of p120RasGAP, a negative regulator of Ras (30, 32, 36, 42).
In addition, EphB1 activation does not inhibit MAPK, and this may be
explained by its strong association with Grb2 and inability to bind
p120RasGAP (24). On the other hand, activated EphB2 induces down-
regulation of MAPK activity because it recruits p120RasGAP but not
Grb2 (32). These divergent pathways activated by different Eph recep-
tors may account for cell type-specific cellular responses.
In this context we propose that LMW-PTP interferes with the eph-
rin-mediated signal toward MAPKs, acting on specific tyrosine-phos-
phorylated sites of EphA2 kinase. LMW-PTP is here reported to regu-
late negatively the binding to activated EphA2 of p120RasGAP, and we
suggest that this causes the block of MAPK inhibition. The binding of
p120RasGAP has been described for the EphB2 receptor during axonal
guidance, and the two juxtamembrane phosphotyrosines have been
proposed as docking sites for its SH2 domain (33).We now confirm that
p120RasGAP actually binds to EphA2 receptor as well. Our data pro-
pose p120RasGAP as a signal transducer of EphA2 kinase during epi-
thelial cell retraction response, demonstrating that it is mainly respon-
sible for the EphA2-mediated MAPK inhibition, indicating this SH2
containing adapter as a general mediator of ephrin-dependent motility
control. Evidence shows that the binding of both p120RasGAP and
LMW-PTP to EphA2 is limited to ligand-activated receptors and
guarded mainly by the two juxtamenbrane tyrosines, namely Tyr-588
and Tyr-594. Thus, upon ligand binding, the competition of LMW-PTP
and p120RasGAP for the same phosphorylated tyrosines may lead to
dephosphorylation of these sites, to the decrease of p120RasGAP bind-
ing to activated receptor, and to the abolishment of the ephrin-mediated
inhibition in MAPK signaling.
In conclusion, our present findings indicate that LMW-PTP has a
key role in the modulation of ephrinA1 repulsive outcome and that
this phosphatase belongs to the biochemical machinery functionally
engaged by the ligand to guarantee the completion of the repulsive
response. We underline that although it ephrins are thought to be
not merely ligands but to have biological activity independent of the
kinase activity of their cognate Eph receptor, our findings merge the
accumulating evidence that the biological responses mediated by the
ephA/EphA system are essentially played by the Eph receptor via
signaling pathways actually involving intracellular tyrosine
phosphorylation.
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